Loading...
NYSE: MRK
Merck & Co., Inc.
Healthcare · Drug Manufacturers - General
●S&P 500 since 1957
Market Cap
$281.41B
52w High
$125.14
52w Low
$73.31
P/E
15.53
Volume
3.38M
Outstanding Shares
2.47B
Company profile
Merck & Co., Inc. operates as a healthcare company worldwide.
CEORobert Davis
SectorHealthcare
IndustryDrug Manufacturers - General
Employees73,000
IPO dateJan 13, 1978
Valuation
Forward P/E—
EV/EBITDA11.83
Enterprise value$299.9B
Stock splits
Jun 3, 2021131:125
Feb 17, 19992:1
May 26, 19923:1
May 26, 19883:1
May 27, 19862:1
Jun 1, 19722:1
May 27, 19643:1
Profitability & growth
Revenue growth4.97%
Gross margin81.5%▲6.78%vs FY2024
Operating margin41.19%▲30.71%vs FY2024
ROE34.7%▼6.11%vs FY2024
Analyst consensus
RatingBuy
Target price$128.54▲12.93%
24
Buy
11
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 30, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$2.13
$2.03
Q3FY25
ActualEst.
$2.58
$2.36
Q4FY25
ActualEst.
$2.04
$2.01
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$15.81B
$15.86B
Q3FY25
ActualEst.
$17.28B
$16.98B
Q4FY25
ActualEst.
$16.4B
$16.2B
Q1FY26
Next Est.
—